Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Vereecke

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Clinical and Translational Medicine|October 14, 2022
The bacterial quorum sensing peptide iAM373 is a novel inducer of sarcopeniaAnton De Spiegeleer, Evelien Wynendaele, Amélie Descamps, et al.
Cell Death and Differentiation|December 2, 2020
Ileal immune tonus is a prognosis marker of proximal colon cancer in mice and patientsMarion Picard, Satoru Yonekura, Karolina Slowicka, et al.
Nature Cancer|February 5, 2022
Publisher Correction: Zeb2 drives invasive and microbiota-dependent colon carcinomaKarolina Slowicka, Ioanna Petta, Gillian Blancke, et al.
European Journal of Immunology|May 10, 2025
VSIG4-Expressing Macrophages Contribute to Antiparasitic and Antimetastatic Responses in the Peritoneal CavityEls Lebegge, Daliya Kancheva, Jolien Van Craenenbroeck, et al.
Nature Cancer|February 5, 2022
Zeb2 drives invasive and microbiota-dependent colon carcinomaKarolina Slowicka, Ioanna Petta, Gillian Blancke, et al.
Journal for Immunotherapy of Cancer|February 16, 2021
Therapeutic depletion of CCR8<sup>+</sup> tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapyHelena Van Damme, Bruno Dombrecht, Máté Kiss, et al.
Cancer Research|September 17, 2025
Depleting IL1R2+ Tumor-Infiltrating Regulatory T Cells with an ADCC-Prone Nanobody Construct Boosts the Efficacy of Anti-PD-1 ImmunotherapySana M Arnouk, Daliya Kancheva, Helena Van Damme, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Clinical and Translational Medicine|October 14, 2022
The bacterial quorum sensing peptide iAM373 is a novel inducer of sarcopeniaAnton De Spiegeleer, Evelien Wynendaele, Amélie Descamps, et al.
Cell Death and Differentiation|December 2, 2020
Ileal immune tonus is a prognosis marker of proximal colon cancer in mice and patientsMarion Picard, Satoru Yonekura, Karolina Slowicka, et al.
Nature Cancer|February 5, 2022
Publisher Correction: Zeb2 drives invasive and microbiota-dependent colon carcinomaKarolina Slowicka, Ioanna Petta, Gillian Blancke, et al.
European Journal of Immunology|May 10, 2025
VSIG4-Expressing Macrophages Contribute to Antiparasitic and Antimetastatic Responses in the Peritoneal CavityEls Lebegge, Daliya Kancheva, Jolien Van Craenenbroeck, et al.
Nature Cancer|February 5, 2022
Zeb2 drives invasive and microbiota-dependent colon carcinomaKarolina Slowicka, Ioanna Petta, Gillian Blancke, et al.
Journal for Immunotherapy of Cancer|February 16, 2021
Therapeutic depletion of CCR8<sup>+</sup> tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapyHelena Van Damme, Bruno Dombrecht, Máté Kiss, et al.
Cancer Research|September 17, 2025
Depleting IL1R2+ Tumor-Infiltrating Regulatory T Cells with an ADCC-Prone Nanobody Construct Boosts the Efficacy of Anti-PD-1 ImmunotherapySana M Arnouk, Daliya Kancheva, Helena Van Damme, et al.
Pageof 6